Gastrointestinal Cancer News

The FDA granted priority review to fam-trastuzumab deruxtecan-nxki for treatment of HER2-positive metastatic gastric cancer or gastroesophageal junction adenocarcinoma.

All adults should begin to get screened for colorectal cancer at age 45 years, according to a draft recommendation by the U.S. Preventive Services Task Force.

Statins used in the general population conferred a 20% risk reduction for colorectal cancer with a possibly larger impact in patients with inflammatory bowel disease, according to an analysis presented during ACG 2020 Virtual.

The mean age of patients with colorectal cancer has dropped in recent years, with a higher proportion of patients aged 40 to 50 years, according to research presented at the American College of Gastroenterology Virtual Annual Scientific Meeting.

The FDA approved the FoundationOne CDx test to help identify certain neurotrophic receptor tyrosine kinase gene fusions in patients with solid tumors eligible for treatment with larotrectinib, according to a press release from the agency.

Black patients with colorectal liver metastases had a lower likelihood of undergoing chemotherapy or resection and shorter survival than their counterparts of other races and ethnicities, according to a research letter in JAMA Network Open.

Four Cleveland Clinic oncology staff members have been appointed to new roles at Taussig Cancer Institute.

Resection of colorectal liver metastases, often performed in conjunction with chemotherapy, can substantially extend survival — a fact that has been acknowledged for about 20 years.

In this podcast episode, we interview Barry Marshall, AC, FRACP, FRS, FAA, the legendary Nobel Laureate who discovered that peptic ulcer disease was caused by the bacteria Helicobacter pylori, not excess acid.

The FDA granted orphan drug designation to APX005M for the treatment of three gastrointestinal cancer types, according to the agent’s manufacturer.